Feature Article | EIT Pharma: Interview With CEO Leen Kawas About Advancing Therapies For Hepatitis D And Viral Diseases

Pulse 2.0 sat down with Dr. Leen Kawas to talk about how EIT Pharma is built around a simple but demanding premise: find promising therapies that haven’t reached their potential, and give them the leadership and execution they need to get to patients. The interview covers her path from pharmacist to biotech CEO, the lonafarnib program for chronic hepatitis D, and what patient-centered drug development actually looks like in practice.

Read the Full Article Here